Eric Del Cotto – General Manager, Owen Mumford Southern Europe and…
Eric Del Cotto, general manager of Owen Mumford Southern Europe and Northern Africa, explains the challenges in market access for SMEs in France. He also gives an overview of Owen…
The Pfizer group has been established for over 50 years in France.
More than 3 000 employees who work daily in the various activities of the company, serving healthcare professionals and patients.
Clinical research: more than 80 physicians, pharmacists, scientists and technicians at the company headquarters in Paris and in different regions of France, ensure the proper conduct of clinical trials initiated by Pfizer
Production: 3 sites in the Val de Loire Alsace and Brittany, the Group’s employees contribute to Pfizer Manufacturing
Pharmaceutical Operations • Human health: employees with headquarters in Paris and visiting medical teams throughout the country. Pfizer is the first drug maker in the world and second in the French market
Cardiology
Pain
Endocrinology
Infectious disease
Ophthalmology
Oncology
Pulmonology
Rheumatology
Central Nervous System
Urology
Contact:
Address: 23-25 avenue du Dr. Lannelongue 75668 Paris Cedex 14,France
Tel: +33 (0)1 58 07 30 00
Eric Del Cotto, general manager of Owen Mumford Southern Europe and Northern Africa, explains the challenges in market access for SMEs in France. He also gives an overview of Owen…
LEEM – Les Entreprises du Médicament (Drug Companies) Key people: Philippe Tcheng, President Philippe Lamoureux, Director LEEM is the French industry association which represents drug companies operating in France…
ANSM – Agence Nationale de Sécurité des Médicaments et des Produits de Santé (National Agency for the Safety of Drugs and Health Products) Key People: Dominique Martin, CEO The National Agency…
Marc Julien, co-CEO of Diabeloop, presents the revolutionary “artificial pancreas” the company has developed to support type one diabetes patients. The device embeds artificial intelligence to help type one diabetics…
Vincent Poher, founder of Avalun, explains the key technology behind the establishment of the company as well as their forthcoming expansion strategy. He also outlines the main challenges start-ups can…
In an exclusive interview, Yves L’Epine, president of G5 Santé and CEO of Guerbet, offers his insider take on the business climate in French healthcare and the potential for France…
INCa – Institut National du Cancer (The National Cancer Institute) The National Cancer Institute (INCa) is the state agency of health and scientific expertise in oncology in…
DSS Direction de la Sécurité (Department of Social Security) Key People: Director General Mathilde Lignot-Leloup The Directorate of Social Security (DSS) supervises all social security organizations: general scheme funds,…
Commission des Affaires Sociales de l’Assemblée Nationale (Commission of Social Affairs, National Assembly) Key People: Brigitte Bourguignon, Chairwoman Olivier Véran, General Reporter The Social Affairs Committee of the National Assembly is…
Joël Jaouen, president of France Alzheimer, provides important insights into the role and objectives of the patient association. He explains why France Alzheimer together with other learned societies filed a…
PharmaBoardroom’s list of personalities whose voices, opinions and decisions matter in French pharma’s industry, regulatory affairs, reimbursement and pricing. Maurice-Pierre Planel — President of CEPS Maurice-Pierre Planel Has been…
Lundbeck France and Benelux’s Lourdes Pla discusses Europe-wide restructuring, the importance of the French affiliate to the global group and the government’s attitude towards healthcare and neuroscience. We are…
See our Cookie Privacy Policy Here